Aurelia Private Equity logo

Aurelia Private Equity

Europe, Hessen, Germany, Frankfurt

Description

Aurelia Private Equity is focused on investments in early-stage technology companies in Germany.

Investor Profile

Aurelia Private Equity has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Series A rounds (top funding stages).
  • Majority of deals are located in Germany, Singapore.
  • Strong thematic focus on Biotechnology, 3D Technology, Apps.

Stage Focus

  • Series C (60%)
  • Series B (20%)
  • Series A (20%)

Country Focus

  • Germany (80%)
  • Singapore (20%)

Industry Focus

  • Biotechnology
  • 3d Technology
  • Apps
  • Communities
  • Digital Entertainment
  • Messaging
  • Music
  • Social Network
  • Virtual World
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Aurelia Private Equity frequently co-invest with?

HP
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 1
BC Brandenburg Capital
Europe, Brandenburg, Germany, Potsdam
Co-Investments: 2
3i Group
Europe, England, United Kingdom, London
Co-Investments: 1
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 1
Aravis Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Rosetta Capital
Europe, England, United Kingdom, London
Co-Investments: 1
Brandenburg Kapital
Europe, Brandenburg, Germany, Potsdam
Co-Investments: 1
Generis Capital Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
EDBI
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Innoven Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1

What are some of recent deals done by Aurelia Private Equity?

GILUPI

Potsdam, Brandenburg, Germany

GILUPI is a Germany-based company that develops medical devices for the in vivo isolation of rare cells out of circulating blood.

BiotechnologyHealth CareMedicalMedical Device
Series CJan 13, 2011
Amount Raised: $4,798,260
Club Cooee

Kaiserslautern, Rheinland-Pfalz, Germany

Club Cooee is a 3D social network where millions of users from all over the world meet and connect in user-generated rooms.

3D TechnologyAppsCommunitiesDigital EntertainmentMessagingMusicSocial NetworkVirtual World
Series BOct 27, 2010
MerLion Pharma

Singapore, Central Region, Singapore

MerLion Pharmaceuticals is a drug discovery and development company that researches and develops natural products.

BiotechnologyPharmaceutical
Series COct 11, 2010
Amount Raised: $7,000,000
Club Cooee

Kaiserslautern, Rheinland-Pfalz, Germany

Club Cooee is a 3D social network where millions of users from all over the world meet and connect in user-generated rooms.

3D TechnologyAppsCommunitiesDigital EntertainmentMessagingMusicSocial NetworkVirtual World
Series AOct 20, 2007
Combinature Biopharm

Berlin, Berlin, Germany

Combinature Biopharm is a drug discovery and development company.

Biotechnology
Series CMay 8, 2006
Amount Raised: $5,110,000